메뉴 건너뛰기




Volumn 86, Issue 2, 2016, Pages 154-160

Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SIMVASTATIN;

EID: 84954315059     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002118     Document Type: Article
Times cited : (27)

References (33)
  • 1
    • 75449091572 scopus 로고    scopus 로고
    • Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service
    • Evans DG, Howard E, Giblin C, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 2010;152A: 327-332.
    • (2010) Am J Med Genet A , vol.152 A , pp. 327-332
    • Evans, D.G.1    Howard, E.2    Giblin, C.3
  • 2
    • 0024456038 scopus 로고
    • A genetic study of von Recklinghausen neurofibromatosis in south east Wales: I: Prevalence, fitness, mutation rate, and effect of parental transmission on severity
    • Huson SM, Compston DA, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales: I: prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 1989;26:704-711.
    • (1989) J Med Genet , vol.26 , pp. 704-711
    • Huson, S.M.1    Compston, D.A.2    Clark, P.3    Harper, P.S.4
  • 3
    • 33847316896 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
    • Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007;44:81-88.
    • (2007) J Med Genet , vol.44 , pp. 81-88
    • Ferner, R.E.1    Huson, S.M.2    Thomas, N.3
  • 4
    • 26444599545 scopus 로고    scopus 로고
    • The nature and frequency of cognitive deficits in children with neurofibromatosis type 1
    • Hyman SL, Shores A, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 2005;65:1037-1044.
    • (2005) Neurology , vol.65 , pp. 1037-1044
    • Hyman, S.L.1    Shores, A.2    North, K.N.3
  • 5
    • 47549115330 scopus 로고    scopus 로고
    • Impact of neurofibromatosis type 1 on school performance
    • Krab LC, Aarsen FK, de Goede-Bolder A, et al. Impact of neurofibromatosis type 1 on school performance. J Child Neurol 2008;23:1002-1010.
    • (2008) J Child Neurol , vol.23 , pp. 1002-1010
    • Krab, L.C.1    Aarsen, F.K.2    De Goede-Bolder, A.3
  • 6
    • 84872595392 scopus 로고    scopus 로고
    • Behaviour in children with neurofibromatosis type 1: Cognition, executive function, attention, emotion, and social competence
    • Lehtonen A, Howie E, Trump D, Huson SM. Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence. Dev Med Child Neurol 2013;55:111-125.
    • (2013) Dev Med Child Neurol , vol.55 , pp. 111-125
    • Lehtonen, A.1    Howie, E.2    Trump, D.3    Huson, S.M.4
  • 7
    • 79952707339 scopus 로고    scopus 로고
    • Motor learning in children with neurofibromatosis type i
    • Krab LC, de Goede-Bolder A, Aarsen FK, et al. Motor learning in children with neurofibromatosis type I. Cerebellum 2011;10:14-21.
    • (2011) Cerebellum , vol.10 , pp. 14-21
    • Krab, L.C.1    De Goede-Bolder, A.2    Aarsen, F.K.3
  • 8
    • 27644517404 scopus 로고    scopus 로고
    • The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1
    • Li W, Cui Y, Kushner SA, et al. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 2005;15:1961-1967.
    • (2005) Curr Biol , vol.15 , pp. 1961-1967
    • Li, W.1    Cui, Y.2    Kushner, S.A.3
  • 9
    • 77958498935 scopus 로고    scopus 로고
    • Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice
    • Brown JA, Emnett RJ, White CR, et al. Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. Hum Mol Genet 2010; 19:4515-4528.
    • (2010) Hum Mol Genet , vol.19 , pp. 4515-4528
    • Brown, J.A.1    Emnett, R.J.2    White, C.R.3
  • 10
    • 84878818929 scopus 로고    scopus 로고
    • Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice
    • Wozniak DF, Diggs-Andrews KA, Conyers S, et al. Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice. PLoS One 2013;8:e66024.
    • (2013) PLoS One , vol.8 , pp. e66024
    • Wozniak, D.F.1    Diggs-Andrews, K.A.2    Conyers, S.3
  • 11
    • 84946489244 scopus 로고    scopus 로고
    • HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1
    • Apr 28
    • Omrani A, Vander Vaart T, Mientjes E, et al. HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1. Mol Psychiatry Epub 2015 Apr 28.
    • (2015) Mol Psychiatry Epub
    • Omrani, A.1    Vander Vaart, T.2    Mientjes, E.3
  • 13
    • 47549111338 scopus 로고    scopus 로고
    • Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: A randomized controlled trial
    • Krab LC, de Goede-Bolder A, Aarsen FK, et al. Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA 2008;300:287-294.
    • (2008) JAMA , vol.300 , pp. 287-294
    • Krab, L.C.1    De Goede-Bolder, A.2    Aarsen, F.K.3
  • 15
    • 84884873014 scopus 로고    scopus 로고
    • Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1
    • Mainberger F, Jung NH, Zenker M, et al. Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1. BMC Neurol 2013;13:131.
    • (2013) BMC Neurol , vol.13 , pp. 131
    • Mainberger, F.1    Jung, N.H.2    Zenker, M.3
  • 16
    • 84885389443 scopus 로고    scopus 로고
    • Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): A randomised, placebo-controlled trial
    • Vander Vaart T, Plasschaert E, Rietman AB, et al. Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial. Lancet Neurol 2013;12:1076-1083.
    • (2013) Lancet Neurol , vol.12 , pp. 1076-1083
    • Vander Vaart, T.1    Plasschaert, E.2    Rietman, A.B.3
  • 17
    • 84991277915 scopus 로고    scopus 로고
    • The effect of methylphenidate on neurofibromatosis type 1: A randomised, double-blind, placebo-controlled, crossover trial
    • Lion-Francois L, Gueyffier F, Mercier C, et al. The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial. Orphanet J Rare Dis 2014;9:142.
    • (2014) Orphanet J Rare Dis , vol.9 , pp. 142
    • Lion-Francois, L.1    Gueyffier, F.2    Mercier, C.3
  • 18
    • 0037246371 scopus 로고    scopus 로고
    • Test reliability and stability of children's cognitive functioning
    • Spencer FH, Bornholt LJ, Ouvrier RA. Test reliability and stability of children's cognitive functioning. J Child Neurol 2003;18:5-11.
    • (2003) J Child Neurol , vol.18 , pp. 5-11
    • Spencer, F.H.1    Bornholt, L.J.2    Ouvrier, R.A.3
  • 19
    • 60249097471 scopus 로고    scopus 로고
    • Health-related quality of life in children with neurofibromatosis type 1: Contribution of demographic factors, disease-related factors, and behavior
    • 425.e421
    • Krab LC, Oostenbrink R, de Goede-Bolder A, Aarsen FK, Elgersma Y, Moll HA. Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior. J Pediatr 2009;154:420-425, 425.e421.
    • (2009) J Pediatr , vol.154 , pp. 420-425
    • Krab, L.C.1    Oostenbrink, R.2    De Goede-Bolder, A.3    Aarsen, F.K.4    Elgersma, Y.5    Moll, H.A.6
  • 20
    • 0030203845 scopus 로고    scopus 로고
    • Children and adolescents with neurofibromatosis 1: A behavioral phenotype
    • Dilts CV, Carey JC, Kircher JC, et al. Children and adolescents with neurofibromatosis 1: a behavioral phenotype. J Dev Behav Pediatr 1996;17:229-239.
    • (1996) J Dev Behav Pediatr , vol.17 , pp. 229-239
    • Dilts, C.V.1    Carey, J.C.2    Kircher, J.C.3
  • 22
    • 84890771989 scopus 로고    scopus 로고
    • Neurofibromatosis type 1 and autism spectrum disorder
    • Garg S, Green J, Leadbitter K, et al. Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics 2013;132: e1642-e1648.
    • (2013) Pediatrics , vol.132 , pp. e1642-e1648
    • Garg, S.1    Green, J.2    Leadbitter, K.3
  • 23
    • 84872586906 scopus 로고    scopus 로고
    • Autism and other psychiatric comorbidity in neurofibromatosis type 1: Evidence from a population-based study
    • Garg S, Lehtonen A, Huson SM, et al. Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Dev Med Child Neurol 2013;55:139-145.
    • (2013) Dev Med Child Neurol , vol.55 , pp. 139-145
    • Garg, S.1    Lehtonen, A.2    Huson, S.M.3
  • 24
    • 84929963400 scopus 로고    scopus 로고
    • Autism spectrum disorder profile in neurofibromatosis type i
    • Garg S, Plasschaert E, Descheemaeker MJ, et al. Autism spectrum disorder profile in neurofibromatosis type I. J Autism Dev Disord 2015;45:1649-1657.
    • (2015) J Autism Dev Disord , vol.45 , pp. 1649-1657
    • Garg, S.1    Plasschaert, E.2    Descheemaeker, M.J.3
  • 25
  • 27
    • 0347746514 scopus 로고    scopus 로고
    • Long-term stability of the child behavior checklist in a clinical sample of youth with attention deficit hyperactivity disorder
    • Biederman J, Monuteaux MC, Greene RW, Braaten E, Doyle AE, Faraone SV. Long-term stability of the child behavior checklist in a clinical sample of youth with attention deficit hyperactivity disorder. J Clin Child Psychol 2001;30:492-502.
    • (2001) J Clin Child Psychol , vol.30 , pp. 492-502
    • Biederman, J.1    Monuteaux, M.C.2    Greene, R.W.3    Braaten, E.4    Doyle, A.E.5    Faraone, S.V.6
  • 28
    • 79960461456 scopus 로고    scopus 로고
    • Assessment of executive function and attention in children with neurofibromatosis type 1: Relationships between cognitive measures and real-world behavior
    • Payne JM, Hyman SL, Shores EA, North KN. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychol 2011;17:313-329.
    • (2011) Child Neuropsychol , vol.17 , pp. 313-329
    • Payne, J.M.1    Hyman, S.L.2    Shores, E.A.3    North, K.N.4
  • 29
    • 84867826988 scopus 로고    scopus 로고
    • The impact of ADHD on the cognitive and academic functioning of children with NF1
    • Pride NA, Payne JM, North KN. The impact of ADHD on the cognitive and academic functioning of children with NF1. Dev Neuropsychol 2012;37:590-600.
    • (2012) Dev Neuropsychol , vol.37 , pp. 590-600
    • Pride, N.A.1    Payne, J.M.2    North, K.N.3
  • 30
    • 84875829967 scopus 로고    scopus 로고
    • Modeling cognitive dysfunction in neurofibromatosis-1
    • Diggs-Andrews KA, Gutmann DH. Modeling cognitive dysfunction in neurofibromatosis-1. Trends Neurosci 2013;36:237-247.
    • (2013) Trends Neurosci , vol.36 , pp. 237-247
    • Diggs-Andrews, K.A.1    Gutmann, D.H.2
  • 31
    • 84885383491 scopus 로고    scopus 로고
    • Challenges of cognitive research in neurofibromatosis type 1
    • Acosta MT. Challenges of cognitive research in neurofibromatosis type 1. Lancet Neurol 2013;12:1040-1041.
    • (2013) Lancet Neurol , vol.12 , pp. 1040-1041
    • Acosta, M.T.1
  • 32
    • 84872299846 scopus 로고    scopus 로고
    • Paired associate learning in children with neurofibromatosis type 1: Implications for clinical trials
    • Payne JM, Barton B, Shores EA, North KN. Paired associate learning in children with neurofibromatosis type 1: implications for clinical trials. J Neurol 2013;260:214-220.
    • (2013) J Neurol , vol.260 , pp. 214-220
    • Payne, J.M.1    Barton, B.2    Shores, E.A.3    North, K.N.4
  • 33
    • 77957990320 scopus 로고    scopus 로고
    • Pilot study of a novel computerized task to assess spatial learning in children and adolescents with neurofibromatosis type 1
    • Ullrich NJ, Ayr L, Leaffer E, Irons MB, Rey-Casserly C. Pilot study of a novel computerized task to assess spatial learning in children and adolescents with neurofibromatosis type 1. J Child Neurol 2010;25:1195-1202.
    • (2010) J Child Neurol , vol.25 , pp. 1195-1202
    • Ullrich, N.J.1    Ayr, L.2    Leaffer, E.3    Irons, M.B.4    Rey-Casserly, C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.